220 related articles for article (PubMed ID: 28141868)
1. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
[TBL] [Abstract][Full Text] [Related]
2. Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.
Sieuwerts AM; Willis S; Burns MB; Look MP; Meijer-Van Gelder ME; Schlicker A; Heideman MR; Jacobs H; Wessels L; Leyland-Jones B; Gray KP; Foekens JA; Harris RS; Martens JW
Horm Cancer; 2014 Dec; 5(6):405-13. PubMed ID: 25123150
[TBL] [Abstract][Full Text] [Related]
3. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
Tokunaga E; Yamashita N; Tanaka K; Inoue Y; Akiyoshi S; Saeki H; Oki E; Kitao H; Maehara Y
PLoS One; 2016; 11(12):e0168090. PubMed ID: 27977754
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers.
Tsuboi M; Yamane A; Horiguchi J; Yokobori T; Kawabata-Iwakawa R; Yoshiyama S; Rokudai S; Odawara H; Tokiniwa H; Oyama T; Takeyoshi I; Nishiyama M
Breast Cancer; 2016 Sep; 23(5):780-8. PubMed ID: 26476745
[TBL] [Abstract][Full Text] [Related]
5. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
[TBL] [Abstract][Full Text] [Related]
6. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
Zhang Y; Delahanty R; Guo X; Zheng W; Long J
Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
Udquim KI; Zettelmeyer C; Banday AR; Lin SH; Prokunina-Olsson L
Carcinogenesis; 2020 Aug; 41(8):1030-1037. PubMed ID: 31930332
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3B is an enzymatic source of mutation in breast cancer.
Burns MB; Lackey L; Carpenter MA; Rathore A; Land AM; Leonard B; Refsland EW; Kotandeniya D; Tretyakova N; Nikas JB; Yee D; Temiz NA; Donohue DE; McDougle RM; Brown WL; Law EK; Harris RS
Nature; 2013 Feb; 494(7437):366-70. PubMed ID: 23389445
[TBL] [Abstract][Full Text] [Related]
11. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
[TBL] [Abstract][Full Text] [Related]
12. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.
Periyasamy M; Patel H; Lai CF; Nguyen VTM; Nevedomskaya E; Harrod A; Russell R; Remenyi J; Ochocka AM; Thomas RS; Fuller-Pace F; Győrffy B; Caldas C; Navaratnam N; Carroll JS; Zwart W; Coombes RC; Magnani L; Buluwela L; Ali S
Cell Rep; 2015 Oct; 13(1):108-121. PubMed ID: 26411678
[TBL] [Abstract][Full Text] [Related]
14. HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
Fan Q; Huang T; Sun X; Wang YW; Wang J; Liu Y; Ni T; Gu SL; Li YH; Wang YD
Mol Carcinog; 2021 May; 60(5):313-330. PubMed ID: 33631046
[TBL] [Abstract][Full Text] [Related]
15. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
[TBL] [Abstract][Full Text] [Related]
16. [APOBEC3B-induced mutagenesis in cancers].
Takaori-Kondo A
Seikagaku; 2016 Oct; 88(5):576-81. PubMed ID: 29624320
[No Abstract] [Full Text] [Related]
17. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.
Christgen M; Christgen H; Heil C; Krech T; Länger F; Kreipe H; Lehmann U
Cancer Sci; 2009 Sep; 100(9):1767-71. PubMed ID: 19549254
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
Harris RS
Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
[TBL] [Abstract][Full Text] [Related]
20. DNA replication stress: a source of APOBEC3B expression in breast cancer.
Cescon DW; Haibe-Kains B
Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
